Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-Current Debt (2018 - 2025)

Dna X (SONM) has disclosed Non-Current Debt for 6 consecutive years, with $250000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Debt changed N/A year-over-year to $250000.0, compared with a TTM value of $250000.0 through Sep 2025, changed N/A, and an annual FY2021 reading of $66000.0, down 64.32% over the prior year.
  • Non-Current Debt was $250000.0 for Q3 2025 at Dna X, down from $566000.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $566000.0 in Q1 2025 and bottomed at $30000.0 in Q1 2022.
  • Average Non-Current Debt over 3 years is $160250.0, with a median of $92500.0 recorded in 2021.
  • Peak annual rise in Non-Current Debt hit 50.0% in 2022, while the deepest fall reached 79.73% in 2022.
  • Year by year, Non-Current Debt stood at $66000.0 in 2021, then tumbled by 43.94% to $37000.0 in 2022, then skyrocketed by 575.68% to $250000.0 in 2025.
  • Business Quant data shows Non-Current Debt for SONM at $250000.0 in Q3 2025, $566000.0 in Q1 2025, and $37000.0 in Q3 2022.